JP2004516252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516252A5 JP2004516252A5 JP2002544024A JP2002544024A JP2004516252A5 JP 2004516252 A5 JP2004516252 A5 JP 2004516252A5 JP 2002544024 A JP2002544024 A JP 2002544024A JP 2002544024 A JP2002544024 A JP 2002544024A JP 2004516252 A5 JP2004516252 A5 JP 2004516252A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24358100P | 2000-10-26 | 2000-10-26 | |
| PCT/US2001/051403 WO2002041843A2 (en) | 2000-10-26 | 2001-10-23 | Antiinflammation agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004516252A JP2004516252A (ja) | 2004-06-03 |
| JP2004516252A5 true JP2004516252A5 (ja) | 2005-12-22 |
| JP4285602B2 JP4285602B2 (ja) | 2009-06-24 |
Family
ID=22919310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002544024A Expired - Fee Related JP4285602B2 (ja) | 2000-10-26 | 2001-10-23 | 抗炎症剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US6846834B2 (ja) |
| EP (1) | EP1333834B1 (ja) |
| JP (1) | JP4285602B2 (ja) |
| KR (1) | KR20030064773A (ja) |
| CN (1) | CN1503673A (ja) |
| AR (1) | AR035499A1 (ja) |
| AT (1) | ATE392898T1 (ja) |
| AU (2) | AU3980602A (ja) |
| BR (1) | BR0114978A (ja) |
| CA (1) | CA2427284A1 (ja) |
| DE (1) | DE60133758T2 (ja) |
| EA (1) | EA200300508A1 (ja) |
| ES (1) | ES2305125T3 (ja) |
| IL (1) | IL155519A0 (ja) |
| MX (1) | MXPA03003599A (ja) |
| NO (1) | NO20031869L (ja) |
| NZ (1) | NZ525474A (ja) |
| PL (1) | PL366114A1 (ja) |
| WO (1) | WO2002041843A2 (ja) |
| ZA (1) | ZA200303203B (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2307278A1 (en) * | 2000-04-28 | 2001-10-28 | University Of British Columbia | Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine |
| BR0114978A (pt) | 2000-10-26 | 2004-04-20 | Tularik Inc | Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares |
| BR0213899A (pt) * | 2001-11-07 | 2004-08-31 | Hoffmann La Roche | Aminopirimidinas e aminopiridinas |
| AR037641A1 (es) | 2001-12-05 | 2004-11-17 | Tularik Inc | Moduladores de inflamacion |
| EP1513516B1 (en) | 2002-06-06 | 2008-12-03 | Boehringer Ingelheim Pharmaceuticals Inc. | SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| EP1556053A4 (en) | 2002-10-31 | 2006-04-19 | Amgen Inc | ANTI-INFLAMMATORY AGENTS |
| EP1587473A4 (en) | 2002-12-27 | 2008-08-13 | Novartis Vaccines & Diagnostic | THIOSEMICARBAZONES ANTIVIRAL AND IMMUNOSTIMULANTS |
| JP2007533602A (ja) | 2003-07-31 | 2007-11-22 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 置換ベンゾチオフェン化合物及びそれらの使用 |
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| TW200626142A (en) | 2004-09-21 | 2006-08-01 | Glaxo Group Ltd | Chemical compounds |
| JP5253159B2 (ja) | 2005-06-24 | 2013-07-31 | デューク・ユニヴァーシティ | 熱応答性バイオポリマーに基づく直接的ドラッグデリバリーシステム |
| UA99699C2 (ru) | 2005-06-30 | 2012-09-25 | Смитклайн Бичам Корпорейшн | Производные индолкарбоксамида и фармацевтическая композиция, которая их содержит |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| JP2009516702A (ja) * | 2005-11-18 | 2009-04-23 | スミスクライン・ビーチャム・コーポレイション | 化合物 |
| GB0523576D0 (en) * | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
| US7592353B2 (en) | 2006-06-06 | 2009-09-22 | Boehringer Ingelheim International Gmbh | Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| DE102007012794B3 (de) * | 2007-03-16 | 2008-06-19 | Novaled Ag | Pyrido[3,2-h]chinazoline und/oder deren 5,6-Dihydroderivate, deren Herstellungsverfahren und diese enthaltendes dotiertes organisches Halbleitermaterial |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| JP2010529031A (ja) * | 2007-05-29 | 2010-08-26 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Ｐｉ３キナーゼ阻害剤としてのナフチリジン誘導体 |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| KR20210107137A (ko) | 2008-04-21 | 2021-08-31 | 오토노미, 인코포레이티드 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 |
| AU2009298981B2 (en) * | 2008-10-02 | 2012-09-27 | Asahi Kasei Pharma Corporation | 8-substituted isoquinoline derivative and use thereof |
| US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
| CA2903081A1 (en) | 2013-03-14 | 2014-09-25 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| CA2961525A1 (en) | 2014-09-16 | 2016-03-24 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| US9896436B2 (en) | 2014-09-16 | 2018-02-20 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| EP3445170A4 (en) * | 2016-04-18 | 2019-11-20 | New York University | CHINOLINE COMPOUNDS AS RAGE ACTIVITY MODULATORS AND USES THEREOF |
| CA3029281A1 (en) | 2016-06-29 | 2018-01-04 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| WO2020176349A1 (en) * | 2019-02-25 | 2020-09-03 | The Regents Of The University Of California | Nnythiosemicarbazone compounds and uses thereof |
| WO2024072870A1 (en) * | 2022-09-28 | 2024-04-04 | New York University | Quinoline compounds as modulators of rage activity and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9317987D0 (en) * | 1993-08-26 | 1993-10-13 | Glaxo Group Ltd | Chemical compounds |
| JP2001526648A (ja) * | 1997-04-22 | 2001-12-18 | コセンシス・インコーポレイテッド | 炭素環及びヘテロ環で置換されたセミカルバゾン及びチオセミカルバゾン、及びその使用 |
| US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
| US6613942B1 (en) * | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
| US6258822B1 (en) | 1997-08-06 | 2001-07-10 | Abbott Laboratories | Urokinase inhibitors |
| RS50340B (sr) | 1999-06-23 | 2009-11-10 | Sanofi-Aventis Deutschland Gmbh., | Supstituisani benzimidazoli |
| DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| WO2001068648A1 (en) | 2000-03-15 | 2001-09-20 | Aventis Pharma Deutschland Gmbh | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| JP4272338B2 (ja) | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
| US6960585B2 (en) | 2000-10-03 | 2005-11-01 | Bristol-Myers Squibb Company | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| WO2002030353A2 (en) | 2000-10-12 | 2002-04-18 | Smithkline Beecham Corporation | NF-λB INHIBITORS |
| WO2002030423A1 (en) | 2000-10-12 | 2002-04-18 | Smithkline Beecham Corporation | NF-λB INHIBITORS |
| BR0114978A (pt) | 2000-10-26 | 2004-04-20 | Tularik Inc | Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares |
| JP2002193938A (ja) | 2000-12-01 | 2002-07-10 | Bayer Ag | ４−アリールピリジン誘導体 |
| US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| CZ20032287A3 (cs) | 2001-02-01 | 2004-02-18 | Bristol-Myers Squibb Company | Způsoby léčení zánětlivých a imunitních nemocí za použití inhibitorů IkB kinázy (IKK) |
| WO2002076985A1 (en) | 2001-03-23 | 2002-10-03 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
-
2001
- 2001-10-23 BR BR0114978-4A patent/BR0114978A/pt not_active IP Right Cessation
- 2001-10-23 DE DE60133758T patent/DE60133758T2/de not_active Expired - Fee Related
- 2001-10-23 WO PCT/US2001/051403 patent/WO2002041843A2/en active IP Right Grant
- 2001-10-23 IL IL15551901A patent/IL155519A0/xx unknown
- 2001-10-23 AT AT01987605T patent/ATE392898T1/de not_active IP Right Cessation
- 2001-10-23 ES ES01987605T patent/ES2305125T3/es not_active Expired - Lifetime
- 2001-10-23 EA EA200300508A patent/EA200300508A1/ru unknown
- 2001-10-23 AU AU3980602A patent/AU3980602A/xx active Pending
- 2001-10-23 CN CN01821344.8A patent/CN1503673A/zh active Pending
- 2001-10-23 KR KR10-2003-7005797A patent/KR20030064773A/ko not_active Application Discontinuation
- 2001-10-23 CA CA002427284A patent/CA2427284A1/en not_active Abandoned
- 2001-10-23 NZ NZ525474A patent/NZ525474A/en unknown
- 2001-10-23 EP EP01987605A patent/EP1333834B1/en not_active Expired - Lifetime
- 2001-10-23 JP JP2002544024A patent/JP4285602B2/ja not_active Expired - Fee Related
- 2001-10-23 PL PL01366114A patent/PL366114A1/xx unknown
- 2001-10-23 MX MXPA03003599A patent/MXPA03003599A/es active IP Right Grant
- 2001-10-23 AU AU2002239806A patent/AU2002239806B2/en not_active Ceased
- 2001-10-23 US US10/004,287 patent/US6846834B2/en not_active Expired - Fee Related
- 2001-10-29 AR ARP010105038A patent/AR035499A1/es not_active Application Discontinuation
-
2003
- 2003-04-24 ZA ZA200303203A patent/ZA200303203B/en unknown
- 2003-04-25 NO NO20031869A patent/NO20031869L/no not_active Application Discontinuation
-
2004
- 2004-08-26 US US10/928,784 patent/US7186841B2/en not_active Expired - Fee Related
-
2007
- 2007-01-05 US US11/650,268 patent/US20070135464A1/en not_active Abandoned